Objective: To estimate national prevalence and direct incremental expenditures in Chronic Obstructive Pulmonary Disease (COPD) and asthma using 2007 Medical Expenditure Panel Survey (MEPS) data.
<br>Methods: COPD and asthma were identified using ICD-9 codes and were the main independent variables. Covariates included age, gender, race, income, region, insurance and marital status. Dependent variables were total health care, office-based, outpatient, inpatient, emergency room and prescription expenditures. Descriptive statistics and regression analysis were used to fulfill the study objectives.
<br>Results: Prevalence of COPD and asthma was 1.3 million and 28.3 million, respectively. Total direct incremental health care expenditures per person for COPD and asthma were $1,739.27 and $2,133.83, respectively. High cost categories among COPD and asthma included office-based, inpatient and prescription expenditures. Age, gender, region, insurance and marital status were significant predictors for health care expenditures.
<br>Conclusion: Results highlight socio-demographic disparities and high health care expenditures due to COPD and asthma in the United States.
<br>Keywords: Asthma, COPD, Medical Expenditures Panel Survey (MEPS), incremental health care expenditures, retrospective analysis / Mylan School of Pharmacy and the Graduate School of Pharmaceutical Sciences / Pharmacy Administration / MS / Thesis
| Identifer | oai:union.ndltd.org:DUQUESNE/oai:digital.library.duq.edu:etd/154121 |
| Date | 18 April 2013 |
| Creators | Srivastava, Bhavini |
| Contributors | Khalid M. Kamal, Jennifer Elliott, Gibbs Kanyongo |
| Source Sets | Duquesne University |
| Detected Language | English |
| Rights | One year embargo: no access to PDF file until release date by author request. |
Page generated in 0.0019 seconds